Product Information
BUTENAFINE HCL 1% CREAM is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.5301 per GM under NDC 51672210008. Its NADAC has been published 46 times since Nov 19, 2025.
FDA first approved this application on Nov 16, 2017.
Strength
10 mg/g
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672210008
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BUTENAFINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205181FDA Approved
11/16/2017
On Market Since
11/17/2017
Pharmacological Classes
Price Statistics
The NADAC for BUTENAFINE HCL 1% CREAM has been published 46 times since Nov 19, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5301 per GM |
|---|---|
| All-time high | $0.5317 (Jun 10, 2026) |
| All-time low | $0.5149 (Feb 18, 2026) |
| 52-week high | $0.5317 |
| 52-week low | $0.5149 |
| Median price | $0.5263 |
| Average price | $0.5245 |
| Largest weekly change | +2.0% (Mar 18, 2026) |
| Weeks tracked | 46 |
| Tracking since | Nov 19, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 42% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Butenafine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUTENAFINE HCL 1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for BUTENAFINE HCL 1% CREAM, manufactured by Sun Pharmaceutical Industries Inc., is $0.5301 per GM (NDC 51672210008), effective Sep 30, 2026.
How has the price of BUTENAFINE HCL 1% CREAM changed over time?
Over the history we have for it, the NADAC for BUTENAFINE HCL 1% CREAM has held within roughly two percent of its current level. It has been tracked across 46 weekly CMS publications since Nov 19, 2025.
What are the highest and lowest recorded NADAC prices for BUTENAFINE HCL 1% CREAM?
Since Nov 19, 2025, the NADAC for BUTENAFINE HCL 1% CREAM has ranged from a low of $0.5149 (Feb 18, 2026) to a high of $0.5317 (Jun 10, 2026), with a median of $0.5263 per GM.
Are there cheaper alternatives to BUTENAFINE HCL 1% CREAM?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUTENAFINE HCL 1% CREAM, is $0.3070 per GM — about 42% below BUTENAFINE HCL 1% CREAM.
Who manufactures BUTENAFINE HCL 1% CREAM?
BUTENAFINE HCL 1% CREAM (NDC 51672210008) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.